Hansen Carl L. G. 4
4 · AbCellera Biologics Inc. · Filed Jan 16, 2024
Insider Transaction Report
Form 4
Hansen Carl L. G.
DirectorChief Executive Officer10% Owner
Transactions
- Award
Share option (right to buy)
2024-01-14+2,095,532→ 8,484,723 totalExercise: $5.39Exp: 2034-01-14→ Common Shares (2,095,532 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.